By iPhone or web, parity in learning

By iPhone or web, parity in learning
By iPhone or web, parity in learning

Learners on smartphone vs. those who are using the web perform about equally well in most outcomes measures, but online CME activities have a higher completion rate, an analysis showed.

Epocrates and RealCME examined data from their own web and iPhone offerings. Subjects, numbering in the tens of thousands, ranged from physicians to medical students, nurses, nurse practitioners, physican  assistants, pharmacists and other healthcare providers, over a range of specialties.

There was no difference cited between the two channels in any of the domains, which included knowledge, competence, confidence and practice. “We don't see a disadvantage in people taking their activity on a smart phone vs. the web in terms of concentration or attention to activity,” said RealCME CEO Steven Haimowitz, MD.

Nor was there any disparity between the two channels when measured in terms of retention. “We found absolutely consistent data…from both an initial gain and a retention gain [with follow-up survey questions sent 8-12 weeks after the activity],” he added.

On the engagement side, however, the analysis offered up  some surprises. “One question people had was you can't do long activities on the phone—you'll lose people,” said Haimowitz. “We're seeing no difference in short vs. long activities on a mobile and online.”

Also, there was a 10% difference in activity completion rates between mobile (61%) and web (72%), with the web channel likely to elicit more completed activities (N=70,000).

In addition, researchers found that  mobile seemed to be more format-sensitive than the web. That is, completion rates for mobile activities fell from about 61% for structured activities to about 42% for unstructured ones. Web activities were not subject to the same influence.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.